IMMUNOPRECISE ANTIBODIES LTD. (HYFT)
MindWalks Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns
📈 **POSITIVE** • High confidence analysis (85%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business